DPPC-d4

CAT: 0804-HY-109506S4-01Size: 1 mgDry Ice: NoHazardous: No
CAT#:0804-HY-109506S4-01Size:1 mg
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
DPPC-d4 is deuterium labeled DPPC. DPPC (129Y83) is a zwitterionic phosphoglyceride that can be used for the preparation of liposomal monolayers. DPPC-liposome serves effectively as a delivery vehicle for inducing immune responses against GSL antigen in m
CAS Number
[326495-33-4]
Product Name Alternative
129Y83-d4
UNSPSC
12352211
Hazard Statement
H302, H315, H319, H331, H336, H351, H361, H372, H412
Target
Endogenous Metabolite; Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
Metabolic Enzyme/Protease; Others
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Others
Purity
99
Solubility
Ethanol : 25 mg/mL (ultrasonic; warming)
Smiles
CCCCCCCCCCCCCCCC(OC[C@@H](OC(CCCCCCCCCCCCCCC)=O)COP(OC([2H])([2H])C([2H])([N+](C)(C)C)[2H])([O-])=O)=O
Molecular Formula
C40H76D4NO8P
Molecular Weight
738.06
Precautions
H302, H315, H319, H331, H336, H351, H361, H372, H412
References & Citations
[1]Miller AD. Delivery of RNAi therapeutics: work in progress. Expert Rev Med Devices. 2013 Nov;10 (6) :781-811.|[2]Akiko Uemura, et al. Induction of immune responses against glycosphingolipid antigens: comparison of antibody responses in mice immunized with antigen associated with liposomes prepared from various phospholipids. J Vet Med Sci. 2005 Dec;67 (12) :1197-201.|[3]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-223.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported

Popular Products